|
|
|
|
 |
| Acutaas Chemicals Ltd |
Pharmaceuticals - Indian - Bulk Drugs |
|
|
| BSE Code |
|
| 543349 |
|
|
|
| ISIN Demat |
|
| INE00FF01025 |
|
|
|
| Book Value |
|
| 173.0280624 |
|
|
|
| Mar.Cap(Rs.Cr) |
|
| 13,350.31 |
|
|
|
| P/E |
|
| 59.15 |
|
|
|
| Face Value |
|
| 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High(Rs) |
Low(Rs) |
Close(Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs. In Cr.) |
| Nov 2025 |
1,901.35 |
1,659.45 |
1,837.05 |
99.95 |
83.33 |
95.19 |
15,040.13 |
| Oct 2025 |
1,865.25 |
1,290.05 |
1,723.80 |
100.84 |
62.39 |
89.32 |
14,112.94 |
| Sep 2025 |
1,529.10 |
1,306.95 |
1,318.80 |
80.53 |
67.11 |
68.34 |
10,797.16 |
| Aug 2025 |
1,444.05 |
1,263.95 |
1,405.30 |
75.92 |
64.52 |
72.82 |
11,505.04 |
| Jul 2025 |
1,345.00 |
1,085.75 |
1,329.10 |
70.53 |
55.52 |
68.87 |
10,881.20 |
| Jun 2025 |
1,187.00 |
1,059.05 |
1,144.35 |
64.98 |
52.63 |
59.30 |
9,368.67 |
| May 2025 |
1,243.00 |
1,080.80 |
1,176.45 |
68.88 |
52.77 |
60.96 |
9,631.47 |
| Apr 2025 |
1,276.10 |
930.03 |
1,130.50 |
68.17 |
50.56 |
58.58 |
9,255.28 |
| Mar 2025 |
1,274.98 |
1,021.25 |
1,220.78 |
67.51 |
50.37 |
63.26 |
9,994.35 |
| Feb 2025 |
1,321.75 |
1,042.50 |
1,085.13 |
184.76 |
139.30 |
150.50 |
8,883.80 |
| Jan 2025 |
1,204.05 |
919.63 |
1,192.05 |
170.56 |
124.62 |
165.33 |
9,759.18 |
| Share Prices Of
2024
|
| Dec 2024 |
1,180.70 |
1,004.03 |
1,074.20 |
183.10 |
133.69 |
148.98 |
8,794.36 |
| Nov 2024 |
1,092.33 |
967.30 |
1,071.95 |
163.50 |
127.17 |
148.67 |
8,775.94 |
| Oct 2024 |
995.73 |
727.50 |
988.43 |
139.12 |
95.02 |
137.09 |
8,092.13 |
| Sep 2024 |
910.00 |
675.60 |
871.18 |
133.87 |
92.72 |
120.80 |
7,131.00 |
| Aug 2024 |
699.58 |
600.00 |
692.10 |
98.06 |
79.42 |
95.97 |
5,665.19 |
| Jul 2024 |
725.63 |
616.55 |
668.08 |
102.75 |
82.07 |
92.59 |
5,465.60 |
| Jun 2024 |
734.78 |
507.23 |
645.55 |
100.66 |
60.99 |
89.47 |
5,281.32 |
| May 2024 |
641.00 |
573.53 |
608.53 |
83.47 |
70.89 |
77.69 |
4,585.81 |
| Apr 2024 |
648.13 |
549.55 |
614.90 |
82.29 |
67.72 |
76.84 |
4,535.57 |
| Prev |
Next
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|